Adding Anakinra and Tocilizumab to Nivolumab and Ipilimumab for the Treatment of Melanoma Patients 50 Years of Age or Older (clinicaltrials.gov) - Sep 25, 2026 - P1 | N=40 | Not yet recruiting | Sponsor: University of Southern California
New P1 trial • Melanoma • Oncology • Solid Tumor
|